Onabotulinumtoxina in the Prevention of Migraine in Pediatric Population: A Systematic Review

Onabotulinumtoxina in the Prevention of Migraine in Pediatric Population: A Systematic Review

Migraine is a leading cause of disability worldwide, yet it remains underrecognized and undertreated, especially in the pediatric and adolescent population. Chronic migraine occurs approximately in 1% of children and adolescents requiring preventive treatment. Topiramate is the only FDA-approved pre...

Full description

Bibliographic Details
Main Authors: Artemis Mavridi, Aine Redmond, Paraschos Archontakis-Barakakis, Petya Bogdanova-Mihaylova, Christina I. Deligianni, Dimos D. Mitsikostas, Theodoros Mavridis
Format: Article
Language:English
Published: MDPI AG 2024-06-01
Series:Toxins
Subjects:
OnabotulinumtoxinA
pediatric migraine
PREEMPT
migraine treatment
chronic migraine
preventive treatment
Online Access:https://www.mdpi.com/2072-6651/16/7/295

Internet

https://www.mdpi.com/2072-6651/16/7/295

Similar Items